Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
Insurance Bill Raises Concerns in FL A fast-moving bill ( SB 1028 ) in Florida, sponsored by Sen. Joe Gruters (R), chairman of the Senate’s Banking and Insurance Committee, would require Citizens...
MS House Passes PBM Reform Bill Mississippi’s House of Representatives passed a bill ( HB 1665 ) that would prohibit pharmacy benefit managers from employing clawbacks when patients’ copayments...
In June, Kansas became the 37th state to offer tax incentives to data centers, underscoring how the massive warehouse-like facilities that support the internet have become a priority for states and state...
States Target Sale of Consumer Geolocation Data Virginia’s Senate Committee on General Laws and Technology advanced a bill ( SB 338 ) that would amend the Virginia Consumer Data Protection Act...
States Easing Up on Certificate of Need Laws Over a dozen states have introduced or are considering legislation this year to scale back their certificate of need (CON) laws requiring healthcare providers...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
California joined a nationwide movement to tighten restrictions on pharmacy benefit managers with the approval of SB 966 days before adjourning its legislative session on Aug. 31. If signed by Gov. Gavin Newsom (D) the measure will establish licensing requirements for PBMs and require them to report to the state’s Department of Insurance the fees they charge pharmacies and the rebates they receive from drug manufacturers. The bill would also require PBMs to pass along 100% of those rebates to health plans or insurers. (PLURIBUS NEWS, LEXISNEXIS STATE NET)
In 2021, Arkansas became the first state to pass a law requiring pharmaceutical manufacturers that participate in Medicaid to sell drugs to contract pharmacies at a discount under the federal 340B program. Louisiana followed suit in 2023. This year, Kansas (SB 28), Maryland (HB 1056), Mississippi (HB 728), Missouri (SB 751) and West Virginia (SB 325) enacted similar legislation. And other states, including New York (AB 7789), considered similar measures.
The recent legislative actions are pushback against the restriction of 340B drug sales by pharmaceutical companies, which contend the 340B program has expanded beyond its original intent. As of September 2023, 25 drugmakers had done so. (STATELINE)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.